Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Aster DM Healthcare...

    Aster DM Healthcare re-files for IPO

    Written by Ruby Khatun Khatun Published On 2017-08-11T09:36:59+05:30  |  Updated On 11 Aug 2017 9:36 AM IST
    Aster DM Healthcare re-files for  IPO

    Mumbai: A draft red herring prospectus (DRHP) has been re-filled by Aster DM Healthcare with a reduced offer size of its initial public offering (IPO).


    Aster DM Healthcare Ltd runs 11 multi-speciality hospitals and 6 clinics in India, 7 hospitals, 89 clinics and 202 retail pharmacies in the GCC states, and one clinic in the Philippines as of 31 March.


    Livemint reports that the company is looking to raise Rs 775 crore in primary capital through a fresh issue of shares and the company will use the proceeds to repay part of its debt and to purchase medical equipment.


    The reason for the reduced offer size was to account for the impact of Aster DM’s main revenue source which is the referral and funding of patients by Saudi Arabia’s ministry of health due to the changes in the economic conditions in Saudi Arabia and lower oil prices ministry has delayed payments.


    In the first DRHP, company had proposed the offer for sale of 36 million shares in which Olympus Capital planned to sell 19 million shares alone and True North, another private equity investor in the firm planned to sell around 4.8 million shares. But now the two Aster DM and Olympus Capital are collectively selling around 16.34 million shares as True North has decided to not sell its stake.


    It is reported that Olympus Capital owns 26.18 percent stake, while True North owns around 11.54 percent stake in the company.


    Syndicate will manage the IPO while three investment banks-Bank of America Merrill Lynch, Edelweiss Financial Services Ltd and SBI Capital Markets Ltd had been dropped by the company with the replacement of Axis Capital and Yes Securities.


    Aster DMAster DM HealthcareAxis CapitalBank of America Merrill LynchclinicsDraft Red Herring ProspectusDRHPEdelweiss Financial Services Ltdhospitalsinitial public offeringIPOmulti speciality hospitalsOlympus Capitalre-filesSBI Capital Markets LtdSyndicateTrue NorthYes Securities
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok